In light of the recent PGT-A class action lawsuit filings in a court in Florida, Vitrolife Group issues the following statement

Vitrolife Group has acknowledged a PGT-A class action lawsuit filed against Vitrolife AB, Vitrolife Inc, and Igenomix USA in the Southern District of Florida court.

Rhea-AI Summary

Vitrolife Group has acknowledged a PGT-A class action lawsuit filed against Vitrolife AB, Vitrolife Inc, and Igenomix USA in the Southern District of Florida court. The company has not yet been formally served with the complaint. The announcement notes that similar class actions were initiated against other industry peers providing PGT-A testing services during Q4 2024.

The company states it will evaluate the class action and its potential scope with US legal counsel and will provide market updates when additional information becomes available.

Positive

• No formal complaint has been served yet
• Company has retained US legal counsel to evaluate and address the situation

Negative

• Company faces potential legal and financial risks from PGT-A class action lawsuit
• Legal proceedings could impact company's PGT-A testing services business

Argus Session date unavailable

-1.89% session move Open Argus

Details

News Market Reaction – VTRLY

The recorded move for VTRLY in the trading session of this news was -1.89%.

Data tracked by StockTitan Argus. Session date unavailable.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

GOTHENBURG, Sweden, March 5, 2025 /PRNewswire/ -- Vitrolife Group is aware that a PGT-A class action lawsuit has been filed against Vitrolife AB (publ), Vitrolife Inc and Igenomix USA, Inc in the court of the Southern District of Florida, although no formal complaint has been served yet. During the fourth quarter of 2024, similar class actions were initiated in the US against other peer companies providing PGT-A testing services. Vitrolife Group will, together with our legal counsel in the US, evaluate the class action and its potential scope and update the market in due course when further information is available.

Gothenburg, 5 March 2025
VITROLIFE AB (publ)
Bronwyn Brophy O'Connor, CEO

Contact:
Amelie Wilson, Investor Relations, awilson@vitrolife.com 

This is a translation of the Swedish version of the press release. When in doubt, the Swedish wording prevails.

This information was brought to you by Cision http://news.cision.com

https://news.cision.com/vitrolife-ab--publ-/r/in-light-of-the-recent-pgt-a-class-action-lawsuit-filings-in-a-court-in-florida--vitrolife-group-iss,c4115061

The following files are available for download:

https://mb.cision.com/Main/1031/4115061/3303768.pdf

In light of the recent PGT-A class action lawsuit filings in a court in Florida, Vitrolife Group issues the following statement

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What is the PGT-A lawsuit against Vitrolife Group (VTRLY) about?

A class action lawsuit has been filed against Vitrolife AB, Vitrolife Inc, and Igenomix USA in Florida regarding PGT-A testing services, though no formal complaint has been served yet.

When were similar PGT-A lawsuits filed against Vitrolife's competitors?

Similar class actions against other companies providing PGT-A testing services were initiated during the fourth quarter of 2024.

How is Vitrolife (VTRLY) responding to the PGT-A class action lawsuit?

Vitrolife Group will evaluate the class action with US legal counsel and update the market when more information becomes available.

Where was the class action lawsuit against Vitrolife (VTRLY) filed?

The lawsuit was filed in the court of the Southern District of Florida.